Skip to main content


News

News
February 19, 2021
Study suggests provider characteristics, like gender and geographic region may play a role in predicting treatment planning of radiation oncology procedures.
News
February 19, 2021
Study suggests provider characteristics, like gender and geographic region may play a role in predicting treatment…
News
February 17, 2021
Acalabrutinib demonstrated favorable PFS and OS compared with standard first-line treatments for CLL, according to a…
News
February 15, 2021
Higher out-of-pocket costs for TKIs are associated with decreased therapy adherence among patients with EGFR- and ALK-…
News
February 13, 2021
Results from a single-center study show payers incur the bulk of monthly PARP inhibitor cost for ovarian cancer.
News
February 11, 2021
Compared with selective internal radiotherapy, sorafenib is not unlikely cost-effective for HCC in the United States.
News
February 11, 2021
Study results show both clinician- and patient-reported performance status are useful for predicting morbidity and…
News
February 09, 2021
Researchers developed a predictive model for identifying admissions of patients with cancer who were potentially…
News
February 08, 2021
Targeted BRCA or multiple gene screening is cost-effective for preventing breast and ovarian cancer, according to a…
News
February 01, 2021
Study findings show 5% of men diagnosed with prostate cancer accounted for 26% of the total cost of care for all men…
News
February 01, 2021
Daratumumab, lenalidomide, and dexamethasone (DRd) yielded faster and sustained clinically meaningful improvements in…
Back to Top